Trials / Completed
CompletedNCT00305539
HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis
HECTHOR: A Pilot Multicenter Double-blind Randomised Study of 3 Months Treatment With Humira Added to Steroids in Giant Cell Arteritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: In giant cell arteritis (GCA), a short initial treatment with anti-TNF may allow a faster decrease of steroids dosage and therefore avoid some of the adverse events of steroids.
Detailed description
The protocol consists of a SC injection of adalimumab or placebo every 2 weeks for 10 weeks added to steroids
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adalimumab | 40 mg sc / for 3 months |
| DRUG | placebo | placebo |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2006-03-22
- Last updated
- 2012-07-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00305539. Inclusion in this directory is not an endorsement.